Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regenxbio Inc. (RGNX)  
$14.92 0.04 (0.27%) as of 4:30 Fri 5/24


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 43,990,000
Market Cap: 656.33(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $12.17 - $24.61
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   REGENXBIO is a clinical-stage biotechnology company. Co.'s product candidates include: RGX-314, which is being developed as a gene therapy for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other additional chronic retinal conditions which cause total or partial vision loss for patients in the U.S., Europe and Japan; RGX-121, which is for the treatment of Mucopolysaccharidosis Type II; RGX-111, which is for the treatment of Mucopolysaccharidosis Type I; RGX-181, which is for the treatment of late infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease; and RGX-381, which is for the treatment of ocular manifestations of CLN2 disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 57,878 180,115 180,115 210,533
Total Sell Value $1,203,255 $3,323,210 $3,323,210 $4,306,417
Total People Sold 2 2 2 3
Total Sell Transactions 4 8 8 15
End Date 2024-02-25 2023-11-24 2023-05-26 2022-05-26

   
Records found: 404
  Page 14 of 17  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Hayden Donald J Jr   –       •      –    2017-09-27 4 AS $32.45 $649,000 D/D (20,000) 0     -
   Hayden Donald J Jr   –       •      –    2017-09-27 4 OE $0.85 $17,000 D/D 20,000 20,000     -
   Mills Kenneth T. President and CEO   •       •      –    2017-09-20 4 AS $29.32 $293,273 D/D (10,000) 108,530     -
   Hayden Donald J Jr   –       •      –    2017-09-18 4 AS $29.95 $599,000 D/D (20,000) 0     -
   Hayden Donald J Jr   –       •      –    2017-09-18 4 OE $0.85 $17,000 D/D 20,000 20,000     -
   Hayden Donald J Jr   –       •      –    2017-09-15 4 AS $27.45 $549,000 D/D (20,000) 0     -
   Hayden Donald J Jr   –       •      –    2017-09-15 4 OE $0.85 $17,000 D/D 20,000 20,000     -
   Vasista Vittal Chief Financial Officer   •       –      –    2017-09-15 4 AS $27.08 $136,925 D/D (5,000) 97,283     -
   Yoo Stephen Chief Medical Officer   •       –      –    2017-09-08 4 AS $25.00 $683,550 D/D (27,342) 0     -
   Yoo Stephen Chief Medical Officer   •       –      –    2017-09-08 4 OE $0.85 $23,241 D/D 27,342 27,342     -
   Yoo Stephen Chief Medical Officer   •       –      –    2017-09-06 4 AS $25.00 $21,375 D/D (855) 0     -
   Yoo Stephen Chief Medical Officer   •       –      –    2017-09-06 4 OE $0.85 $727 D/D 855 855     -
   Mills Kenneth T. President and CEO   •       •      –    2017-09-05 4 AS $25.00 $262,500 D/D (10,500) 118,530     -
   Hayden Donald J Jr   –       •      –    2017-09-05 4 AS $24.95 $499,000 D/D (20,000) 0     -
   Hayden Donald J Jr   –       •      –    2017-09-05 4 OE $0.85 $17,000 D/D 20,000 20,000     -
   Yoo Stephen Chief Medical Officer   •       –      –    2017-09-05 4 AS $25.00 $795,075 D/D (31,803) 0     -
   Yoo Stephen Chief Medical Officer   •       –      –    2017-09-05 4 OE $0.85 $27,033 D/D 31,803 31,803     -
   Mills Kenneth T. President and CEO   •       •      –    2017-08-25 4 OE $0.85 $20,001 D/D 23,530 129,030     -
   Mills Kenneth T. President and CEO   •       •      –    2017-08-21 4 AS $20.05 $130,325 D/D (6,500) 105,500     -
   Yoo Stephen Chief Medical Officer   •       –      –    2017-08-21 4 AS $20.03 $300,450 D/D (15,000) 0     -
   Yoo Stephen Chief Medical Officer   •       –      –    2017-08-21 4 OE $0.85 $12,750 D/D 15,000 15,000     -
   Vasista Vittal Chief Financial Officer   •       –      –    2017-08-15 4 AS $20.96 $64,111 D/D (3,040) 102,283     -
   Mills Kenneth T. President and CEO   •       •      –    2017-07-20 4 AS $18.66 $121,290 D/D (6,500) 112,000     -
   Yoo Stephen Chief Medical Officer   •       –      –    2017-07-20 4 AS $18.66 $279,900 D/D (15,000) 0     -
   Yoo Stephen Chief Medical Officer   •       –      –    2017-07-20 4 OE $0.85 $12,750 D/D 15,000 15,000     -
  404 Records found
  Previous  10  11  12  13  14  15  16  17   
  Page 14 of 17
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us